{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:01:02Z","timestamp":1780336862539,"version":"3.54.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","gastro.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.gtc.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T19:45:32Z","timestamp":1500493532000},"page":"531-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sexuality, Fertility, and Pregnancy in Crohn's Disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Jill K.J.","family":"Gaidos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda V.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.gtc.2017.05.007_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.0953-0673.2003.01727.x","article-title":"Inflammatory bowel disease","volume":"18","author":"Keighley","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.05.007_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.crohns.2012.02.014","article-title":"Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease [IBD] in Germany: an online IBD registry","volume":"7","author":"Bokemeyer","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"issue":"9","key":"10.1016\/j.gtc.2017.05.007_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1155\/1999\/701645","article-title":"Influence of sex and disease on illness-related concerns in inflammatory bowel disease","volume":"13","author":"Maunder","year":"1999","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/00365520310004687","article-title":"What concerns subjects with inflammatory bowel disease and an ileostomy?","volume":"38","author":"Carlsson","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.007_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ibd.21090","article-title":"Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions","volume":"16","author":"Muller","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000201046","article-title":"Perceived sexual dysfunction among patients with inflammatory bowel disease","volume":"54","author":"Moody","year":"1993","journal-title":"Digestion"},{"key":"10.1016\/j.gtc.2017.05.007_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-230X-8-45","article-title":"Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis","volume":"8","author":"Timmer","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/apt.12720","article-title":"Review article: the psychosexual impact of inflammatory bowel disease in male patients","volume":"39","author":"O'Toole","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"3\u20134","key":"10.1016\/j.gtc.2017.05.007_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000200951","article-title":"Sexual dysfunction amongst women with Crohn's disease: a hidden problem","volume":"52","author":"Moody","year":"1992","journal-title":"Digestion"},{"key":"10.1016\/j.gtc.2017.05.007_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cgh.2006.10.018","article-title":"Sexual function in persons with inflammatory bowel disease: a survey with matched controls","volume":"5","author":"Timmer","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.05.007_bib11","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ibd.20182","article-title":"Determinants of male sexual function in inflammatory bowel disease: a survey-based cross-sectional analysis in 280 men","volume":"13","author":"Timmer","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00535-012-0700-2","article-title":"Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey","volume":"48","author":"Marin","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib13","first-page":"23","article-title":"Drug-induced sexual dysfunction and infertility","volume":"3","author":"Beeley","year":"1984","journal-title":"Adverse Drug React Acute Poisoning Rev"},{"key":"10.1016\/j.gtc.2017.05.007_bib14","first-page":"711","article-title":"Sulfasalazine-induced impotence: a beneficial resolution with olsalazine?","volume":"11","author":"Ireland","year":"1989","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib15","first-page":"1821","article-title":"Impotence in a patient with rheumatoid arthritis treated with methotrexate","volume":"27","author":"Thomas","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.gtc.2017.05.007_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/anr.1780321029","article-title":"Impotence in three rheumatoid arthritis patients treated with methotrexate","volume":"32","author":"Blackburn","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.gtc.2017.05.007_bib17","first-page":"558","article-title":"Appearance of impotence in relation to the use of methotrexate","volume":"106","author":"Riba","year":"1996","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.gtc.2017.05.007_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/apt.12478","article-title":"Systematic review: fertility in non-surgically treated inflammatory bowel disease","volume":"38","author":"Tavernier","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.05.007_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528309181559","article-title":"Impaired semen quality in Crohn's disease-drugs, ill health, or undernutrition?","volume":"18","author":"Farthing","year":"1983","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2017.05.007_bib20","first-page":"314","article-title":"Quality of semen in patients with Crohn's disease","volume":"20","author":"Karbach","year":"1982","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/pgmj.62.726.269","article-title":"Male fertility in Crohn's disease","volume":"62","author":"Burnell","year":"1986","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.007_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004836-198908000-00011","article-title":"Male infertility in inflammatory bowel disease","volume":"11","author":"Narendranathan","year":"1989","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.22.6.452","article-title":"Incidence of sulphasalazine-induced male infertility","volume":"22","author":"Birnie","year":"1981","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.05.007_bib24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/gut.25.10.1078","article-title":"Reversible male infertility due to sulphasalazine: studies in man and rat","volume":"25","author":"O'Morain","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.05.007_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/gut.28.8.1008","article-title":"Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution","volume":"28","author":"Riley","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.05.007_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.dld.2003.11.030","article-title":"Mesalazine-induced reversible infertility in a young male","volume":"36","author":"Chermesh","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/01485010490250533","article-title":"Effect of chronic low dose methotrexate on cellular proliferation during spermatogenesis in rats","volume":"50","author":"Saxena","year":"2004","journal-title":"Arch Androl"},{"key":"10.1016\/j.gtc.2017.05.007_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archderm.1980.01640260091025","article-title":"Psoriasis, methotrexate, and oligospermia","volume":"116","author":"Sussman","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.gtc.2017.05.007_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/01485017908985067","article-title":"Methotrexate and fertility in men","volume":"3","author":"El-Beheiry","year":"1979","journal-title":"Arch Androl"},{"key":"10.1016\/j.gtc.2017.05.007_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.0303-4569.2003.00588.x","article-title":"Zinc deficiency in men with Crohn's disease may contribute to poor sperm function and male infertility","volume":"35","author":"El-Tawil","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.gtc.2017.05.007_bib31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ajg.2008.90","article-title":"Sexual and reproductive issues for men with inflammatory bowel disease","volume":"104","author":"Feagins","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.25.1.52","article-title":"Crohn's disease and pregnancy","volume":"25","author":"Khosla","year":"1984","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.007_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-8553(05)70056-X","article-title":"Epidemiology and natural course of inflammatory bowel disease","volume":"28","author":"Andres","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"10.1016\/j.gtc.2017.05.007_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2002.30345","article-title":"Ulcerative colitis: female fecundity before diagnosis, during disease and after surgery compared to a population sample","volume":"122","author":"Ording Olsen","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/gut.2005.090316","article-title":"Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis","volume":"55","author":"Waljee","year":"2006","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gtc.2017.05.007_bib36","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/00365521.1984.12005800","article-title":"Pregnancy in Crohn's disease","volume":"19","author":"Nielsen","year":"1984","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.21.6.469","article-title":"Ulcerative colitis and pregnancy","volume":"21","author":"Willoughby","year":"1980","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.gtc.2017.05.007_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/014107688607900410","article-title":"Inflammatory bowel disease in pregnancy: a review","volume":"79","author":"Miller","year":"1986","journal-title":"J\u00a0R Soc Med"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.007_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/apt.12417","article-title":"Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease","volume":"38","author":"Abhyankar","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.05.007_bib40","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2007.07.019","article-title":"Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California","volume":"133","author":"Mahadevan","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.gastro.2013.09.061","article-title":"Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications","volume":"146","author":"Ban","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2017.05.007_bib42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2010.02.014","article-title":"Crohn's disease is a risk factor for preterm birth","volume":"8","author":"Stephansson","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.05.007_bib43","first-page":"1091","article-title":"Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure","volume":"20","author":"Br\u00f6ms","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib44","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3109\/00365521.2010.503967","article-title":"Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study","volume":"45","author":"Moln\u00e1r","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib45","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ajg.2016.254","article-title":"The effects of active IBD during pregnancy in the era of novel IBD therapies","volume":"111","author":"de Lima-Karagiannis","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2017.05.007_bib46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ibd.20839","article-title":"Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions","volume":"15","author":"Mountifield","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/00365520903362628","article-title":"Reproductive wish represents an important factor in influencing therapeutic strategy in inflammatory bowel diseases","volume":"45","author":"Zelikova","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib48","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.cgh.2016.03.018","article-title":"Preconception care reduces relapse of inflammatory bowel disease during pregnancy","volume":"14","author":"de Lima","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.05.007_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0016-5085(98)70628-6","article-title":"The safety of mesalamine in human pregnancy: a prospective controlled cohort study","volume":"144","author":"Diav-Citrin","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gut.52.2.243","article-title":"Birth outcome in women exposed to 5-aminosalycylic acid during pregnancy: a Danish cohort study","volume":"52","author":"N\u00f8rg\u00e5rd","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.05.007_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.reprotox.2007.11.010","article-title":"Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis","volume":"25","author":"Rahimi","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.gtc.2017.05.007_bib52","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2017.05.007_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wylie","year":"2000","journal-title":"Teratology"},{"issue":"12","key":"10.1016\/j.gtc.2017.05.007_bib54","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/bdra.10134","article-title":"First trimester exposure to corticosteroids and oral clefts","volume":"67","author":"Pradat","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.gtc.2017.05.007_bib55","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0016-5085(14)60002-0","article-title":"Pregnancy outcomes amongst mothers with inflammatory bowel disease exposed to systemic corticosteroids: results of the PIANO registry","volume":"146","author":"Lin","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib56","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1572-0241.2007.01756.x","article-title":"Relapses in inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes","volume":"103","author":"Reddy","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2017.05.007_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.20640","article-title":"Budesonide induction and maintenance therapy for Crohn's disease during pregnancy","volume":"15","author":"Beaulieu","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2008.12.007","article-title":"The safety of quinolones - A meta-analysis of pregnancy outcomes","volume":"143","author":"Bar-Oz","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gtc.2017.05.007_bib59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2125.1997.00660.x","article-title":"Is metronidazole teratogenic? A meta-analysis","volume":"44","author":"Caro-Paton","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.gtc.2017.05.007_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/tera.10043","article-title":"Teratogen update: azathioprine and 6-mercaptopurine","volume":"65","author":"Polifka","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.gtc.2017.05.007_bib61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2036.2003.01537.x","article-title":"Azathioprine, mercaptopurine and birth outcome: a population-based cohort study","volume":"17","author":"N\u00f8rg\u00e5rd","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.05.007_bib62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/gut.2010.222893","article-title":"Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study","volume":"60","author":"Coelho","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.05.007_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systemic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib64","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0016-5085(12)60561-7","article-title":"PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy","volume":"142","author":"Mahadevan","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/apt.12334","article-title":"Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease","volume":"38","author":"De Meij","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2017.05.007_bib66","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1111\/j.1432-2277.2000.tb02043.x","article-title":"Analysis of 100 pregnancy outcomes in women treated systemically with tacrolimus","volume":"13","author":"Kainz","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.gtc.2017.05.007_bib67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007890-199708270-00002","article-title":"Pregnancy after liver transplantation under tacrolimus","volume":"64","author":"Jain","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.gtc.2017.05.007_bib68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib69","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1136\/gut.2005.078972","article-title":"Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis","volume":"54","author":"Baumgart","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.05.007_bib70","first-page":"905","article-title":"Safety of tacrolimus in pregnancy","volume":"60","author":"Nevers","year":"2014","journal-title":"Can Fam Physician"},{"issue":"9","key":"10.1016\/j.gtc.2017.05.007_bib71","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/lt.24182","article-title":"Outcomes of pregnancy following liver transplantation: the King's College Hospital experience","volume":"21","author":"Westbrook","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2017.05.007_bib72","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar-Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.gtc.2017.05.007_bib73","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ibd.21198","article-title":"Safety of adalimumab in Crohn\u2019s disease during pregnancy: case report and review of the literature","volume":"16","author":"J\u00fcrgens","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib74","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib75","doi-asserted-by":"crossref","first-page":"S858","DOI":"10.1016\/S0016-5085(15)32908-5","article-title":"Pregnancy outcomes after exposure to certolizumab pegol: updated results from safety surveillance","volume":"148","author":"Mahadevan","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib76","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1741-7015-11-174","article-title":"Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review","volume":"11","author":"Nielsen","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.gtc.2017.05.007_bib77","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/MIB.0000000000000092","article-title":"Anti-TNF alpha therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis","volume":"20","author":"Narula","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib78","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.12936","article-title":"Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease","volume":"40","author":"Deepak","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.gtc.2017.05.007_bib79","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.MIB.0000440984.86659.4f","article-title":"Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children","volume":"20","author":"Bortlik","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib80","doi-asserted-by":"crossref","first-page":"s170","DOI":"10.1016\/S0016-5085(14)60602-8","article-title":"Exposure to anti-TNFa therapy in the third trimester of pregnancy is not associated with increased adverse outcomes: results from the PIANO registry","volume":"146","author":"Mahadevan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2017.05.007_bib82","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib83","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0016-5085(16)30422-X","article-title":"Do infant serum levels of biologic agents at birth correlate with risk of adverse outcomes? Results from the PIANO registry","volume":"150","author":"Mahadevan","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2015-309321","article-title":"Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety","volume":"65","author":"de Lima","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2017.05.007_bib85","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/apt.12833","article-title":"Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease","volume":"40","author":"Seirafi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.05.007_bib86","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0016-5085(14)60001-9","article-title":"Achievement of developmental milestones among offspring of women with inflammatory bowel disease: the PIANO registry","volume":"146","author":"Mahadevan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2017.05.007_bib87","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2016.10.013","article-title":"Drug safety and risk of adverse outcomes for pregnant patients with inflammatory bowel disease","volume":"152","author":"Mahadevan","year":"2017","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gtc.2017.05.007_bib88","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamaneurol.2014.209","article-title":"Natalizumab use during the third trimester of pregnancy","volume":"71","author":"Haghikia","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.gtc.2017.05.007_bib89","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1352458514546790","article-title":"Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study","volume":"21","author":"Ebrahimi","year":"2015","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.gtc.2017.05.007_bib90","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1177\/1352458511401944","article-title":"Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment","volume":"17","author":"Hellwig","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.gtc.2017.05.007_bib91","doi-asserted-by":"crossref","first-page":"s449","DOI":"10.14309\/00000434-200809001-01150","article-title":"Natalizumab use in pregnancy","volume":"103","author":"Mahadevan","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2017.05.007_bib92","doi-asserted-by":"crossref","unstructured":"Dubinsky M, Mahadevan U, Vermeire S, et\u00a0al. Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. ECCO 2015. p. 563.","DOI":"10.14309\/00000434-201510001-01814"},{"key":"10.1016\/j.gtc.2017.05.007_bib93","unstructured":"Data on file. Reports of pregnancy with ustekinumab: STE\/inj\/DoF\/Sep2010\/EMEA001."},{"issue":"4","key":"10.1016\/j.gtc.2017.05.007_bib94","first-page":"105","article-title":"Spontaneous abortion during ustekinumab therapy","volume":"6","author":"Fotiadou","year":"2012","journal-title":"J\u00a0Dermatol Case Rep"},{"key":"10.1016\/j.gtc.2017.05.007_bib95","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/jdv.12872","article-title":"Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis","volume":"30","author":"Alsenaid","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.gtc.2017.05.007_bib96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000380880","article-title":"Pregnancy during ustekinumab treatment for severe psoriasis","volume":"231","author":"Rocha","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.gtc.2017.05.007_bib97","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajd.12214","article-title":"Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester","volume":"55","author":"Sheeran","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.gtc.2017.05.007_bib98","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gtc.2017.05.007_bib99","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.autrev.2016.07.014","article-title":"Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation","volume":"15","author":"Levy","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.gtc.2017.05.007_bib100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2036.2011.04794.x","article-title":"Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006","volume":"34","author":"Bortoli","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2017.05.007_bib101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/jp.2014.41","article-title":"Association between maternal inflammatory bowel disease and adverse perinatal outcomes","volume":"34","author":"Getahun","year":"2014","journal-title":"J\u00a0Perinatol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855317300614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T23:50:02Z","timestamp":1602546602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855317300614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0889855317300614"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2017.05.007","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexuality, Fertility, and Pregnancy in Crohn's Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}